darunavir has been researched along with AIDS Seroconversion in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baassi, M; Belaaouad, S; Moussaoui, M; Rajkhowa, S; Sharma, A; Sinha, S; Soufi, H | 1 |
| Bruzzone, B; Castagna, A; Di Biagio, A; Labate, L; Santoro, MM; Spagnuolo, V; Zazzi, M | 1 |
| Bailey, AC; Mackie, N; Muir, D; Ring, K | 1 |
| Antinori, A; Bonora, S; Castelli, F; Cattelan, AM; Cauda, R; Celesia, BM; Cossu, MV; d'Arminio Monforte, A; Gianotti, N; Gori, A; Mancusi, D; Manzillo, E; Maserati, R; Menzaghi, B; Orofino, G; Ripamonti, D; Rucci, F; Rusconi, S; Santantonio, TA; Savinelli, S; Sterrantino, G; Stingone, C; Termini, R; Uglietti, A; Vergori, A | 1 |
| Baldin, G; Belmonti, S; Borghetti, A; Ciccullo, A; De Luca, A; Di Giambenedetto, S; Emiliozzi, A; Gagliardini, R; Lamonica, S; Lombardi, F; Montagnani, F; Moschese, D; Visconti, E | 1 |
| Best, BM; Burger, DM; Capparelli, E; Colbers, A; Cressey, TR; Greupink, R; Karlsson, MO; Mirochnick, M; Moltó, J; Russel, FGM; Schalkwijk, S; Ter Heine, R | 1 |
| Averitt Bridge, D; Currier, J; Falcon, R; Feinberg, J; Hagins, D; Mrus, J; Ryan, R; Squires, K; Tennenberg, A; Zorrilla, CD | 1 |
| Annemans, L; Hill, AM; Mauskopf, J; Smets, E | 1 |
| Bigoloni, A; Carini, E; Castagna, A; Cossarini, F; Galli, L; Gianotti, N; Lazzarin, A; Nozza, S; Piatti, P; Salpietro, S; Spagnuolo, V; Vinci, C | 1 |
| Ingiliz, P; Ivanka, K; Krznaric, I; Martin, O; Obermeier, M; Patrick, I | 1 |
1 review(s) available for darunavir and AIDS Seroconversion
| Article | Year |
|---|---|
A review of economic evaluations of darunavir boosted by low-dose ritonavir in treatment-experienced persons living with HIV infection.
Topics: Adult; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Cost-Benefit Analysis; Darunavir; Drug Costs; HIV; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; Humans; Ritonavir; Standard of Care; Sulfonamides | 2010 |
1 trial(s) available for darunavir and AIDS Seroconversion
| Article | Year |
|---|---|
Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial.
Topics: Adolescent; Adult; CD4 Lymphocyte Count; Darunavir; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Mutation; Ritonavir; Sex Factors; Sulfonamides; Viral Load; Young Adult | 2010 |
8 other study(ies) available for darunavir and AIDS Seroconversion
| Article | Year |
|---|---|
Towards designing of a potential new HIV-1 protease inhibitor using QSAR study in combination with Molecular docking and Molecular dynamics simulations.
Topics: Anti-Infective Agents; Darunavir; HIV Protease; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Quantitative Structure-Activity Relationship | 2023 |
PRESTIGIO RING: "A 59-year-old HIV-1 positive, highly treatment-experienced woman failing darunavir/ ritonavir plus raltegravir".
Topics: Anti-HIV Agents; Darunavir; Drug Resistance, Viral; HIV Infections; HIV Seropositivity; HIV-1; Humans; Raltegravir Potassium; Ritonavir; RNA; Treatment Outcome; Viral Load | 2023 |
HIV-1 superinfection in a patient with known HIV-2 - A case report.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cobicistat; Darunavir; Emtricitabine; Female; HIV Infections; HIV Seropositivity; HIV-1; HIV-2; Humans; Male; Middle Aged; Superinfection; Tenofovir; Treatment Outcome | 2020 |
Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The "STORE" Study.
Topics: Adult; Anti-HIV Agents; Cobicistat; Darunavir; Female; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Prospective Studies; Ritonavir; RNA, Viral; Viral Load | 2020 |
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cohort Studies; Darunavir; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Retrospective Studies; Ritonavir; Tenofovir; Treatment Outcome; Viral Load | 2019 |
Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling.
Topics: Anti-HIV Agents; Computer Simulation; Darunavir; Dose-Response Relationship, Drug; Female; Gestational Age; HIV Seropositivity; Humans; Models, Theoretical; Population; Pregnancy; Pregnancy Complications, Infectious; Ritonavir | 2019 |
Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens.
Topics: Anti-HIV Agents; Blood Glucose; Cyclohexanes; Darunavir; Fasting; Glucose Tolerance Test; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Insulin; Insulin Resistance; Maraviroc; Nitriles; Pyridazines; Pyrimidines; Pyrrolidinones; Raltegravir Potassium; Ritonavir; Sulfonamides; Treatment Outcome; Triazoles; Viral Load | 2012 |
Sexually transmitted infection with an immune-escape mutant hepatitis B virus in an hepatitis B virus-vaccinated individual with acute HIV-hepatitis C virus infection.
Topics: Acute Disease; Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Darunavir; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis C; HIV Seropositivity; Homosexuality, Male; Humans; Male; Organophosphonates; Sulfonamides; Tenofovir; Treatment Outcome; Unsafe Sex; Viral Load | 2013 |